Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Chemico-Biological Interactions ; 365, 2022.
Article in English | Web of Science | ID: covidwho-2147672

ABSTRACT

Asthma, COPD, COVID-19, EGPA, Lung cancer, and Pneumonia are major chronic respiratory diseases (or CRDs) affecting millions worldwide and account for substantial morbidity and mortality. These CRDs are irreversible diseases that affect different parts of the respiratory system, imposing a considerable burden on different socioeconomic classes. All these CRDs have been linked to increased eosinophils in the lungs. Eosinophils are essential immune mediators that contribute to tissue homeostasis and the pathophysiology of various diseases. Interestingly, elevated eosinophil level is associated with cellular processes that regulate airway hyperresponsiveness, airway remodeling, mucus hypersecretion, and inflammation in the lung. Therefore, eosinophil is considered the therapeutic target in eosinophil-mediated lung diseases. Although, conventional medicines like antibiotics, antiinflammatory drugs, and bronchodilators are available to prevent CRDs. But the development of resistance to these therapeutic agents after long-term usage remains a challenge. However, progressive development in nanotechnology has unveiled the targeted nanocarrier approach that can significantly improve the pharmacokinetics of a therapeutic drug. The potential of the nanocarrier system can be specifically targeted on eosinophils and their associated components to obtain promising results in the pharmacotherapy of CRDs. This review intends to provide knowledge about eosinophils and their role in CRDs. Moreover, it also discusses nanocarrier drug delivery systems for the targeted treatment of CRDs.

2.
Journal of Food Processing and Preservation ; 2022.
Article in English | Scopus | ID: covidwho-1961635

ABSTRACT

COVID-19 pandemic has increased the demand for antioxidant and micronutrient-rich foods that are easy to prepare, consume, and require less handling. In this research, we worked on the development of nutritious extruded snack made from barnyard millet, defatted soy flour, Indian gooseberry powder, and rice flour. Box–Behnken Design of Response Surface Methodology was utilized to determine the influence of process variables viz;blend ratio of barnyard millet and defatted soy flour, extruder barrel temperature, and Indian gooseberry powder on nutritional and organoleptic properties of snack. Optimized extruded snack were attained at blend ratio (6:1), barrel temperature (115°C), and Indian gooseberry (12.25 g/100 g of total flour). Extruded snack presented good overall acceptability along with high fiber (16.84 g/100 g), protein (18.91 g/100 g), total phenol (67.51 mg GAE/100 g), and total flavonoid (153.61 mg RE/100 g) content. Microbial analysis indicates that extruded snack can be stored for up to 60 days without microbial contamination. Novelty impact statement: The pandemic has made people refocus on the foods that are nutritious, yet take less time to prepare and handle. In the present research, we explored the use of locally available and low-cost barnyard millet and defatted soy flour coupled with Indian gooseberry powder—a rich source of antioxidants and rice flour for the preparation of nutritious snack. Extrudates developed with a higher blend ratio at higher barrel temperature and enriched with Indian gooseberry content displayed excellent nutritional, bioactive, and dimensional characteristics. The study will help formulate extruded snack with high protein, antioxidants, as well as fiber content. © 2022 Wiley Periodicals LLC.

SELECTION OF CITATIONS
SEARCH DETAIL